Hjem › Neuroblastom › Washington
Neuroblastom kliniske forsøg i Washington
6 studier for Neuroblastom søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
RekruttererFase 3
Op til 30 år · Alle køn · Opdateret 2. okt. 2026 · NCT06172296Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- og 1 flere
RekruttererFase 3
365 Days – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03126916SPEARHEAD-3 Pediatric Study
- Seattle Children's Hospital, Seattle
RekruttererFase 1/2
Alder 2 til 21 · Alle køn · Opdateret 11. aug. 2026 · NCT05642455NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Seattle Children's Hospital, Seattle
RekruttererFase 2
Alder 1 til 31 · Alle køn · Opdateret 20. jul. 2026 · NCT06450041Neuroblastoma Biology Study
- Seattle Children's Hospital, Seattle
RekruttererObservationsstudie
31 Days – 99 Years · Alle køn · Opdateret 23. mar. 2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Seattle Children's Hospital, Seattle
Rekrutterer
Op til 17 år · Alle køn · Opdateret 10. feb. 2026 · NCT06831552Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.